Managing Risk in Pharmaceutical R&D
Abstract:OVERVIEW: Risk is a powerful force in innovative organizations for the obvious reason that it means the future outcomes of decisions are uncertain and, less obviously, because it can foster decision biases like loss aversion and over-optimism. Decision biases at one level are often counterbalanced by different biases at other levels of a firm. Two archetypal approaches to managing risk in R&D—so-called “buckshot” vs. “birdshot” risk strategies— hold implications for organizational performance in the face of risk. Historical data from two leading pharmaceutical firms permit exploring these two patterns of strategic decision-making to see how these risk strategies have played out over the ensuing years.
Document Type: Research Article
Publication date: March 1, 2010
More about this publication?
- Research-Technology Management has been publishing peer-reviewed articles covering the entire spectrum of technological innovation since 1958. RTM is a leading source of knowledge and best practices on innovation management, from research and development through product development to marketing, for leaders of research, development, and engineering worldwide.
Not a Subscriber? Free Issue
IRI Members: login here to access RTM online
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- RTM Reprint Collections
- Single Article Reprints
- Recommend to your Library
- ingentaconnect is not responsible for the content or availability of external websites